1.               Centers for Disease Control and Prevention 2019 Novel Coronavirus, Wuhan, China. CDC, 2020. Available at: www.cdc.gov/coronavirus/2019-ncov/about/index.html

2.               Wee S-L, McNeil GD, Hernández JC. W.H.O. declares global emergency as Wuhan coronavirus spreads. New York Times, 30 January 2020.

3.               Дедов И.И., Шестакова М.В., Мельниченко Г.А. и др. Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний». Ожирение и метаболизм 2021; 18 (1): 5–99. DOI: 10.14341/omet12714

[Dedov II, Shestakova MV, Melnichenko GA et al. Interdisciplinary clinical practice guidelines “Management of obesity and its comorbidities”. Obesity and metabolism 2021; 18 (1): 5–99. DOI: 10.14341/omet12714 (in Russian)].

4.               Zhang X, Zhang M, Zhao Z et al. Geographic Variation in Prevalence of Adult Obesity in China: Results From the 2013–2014 National Chronic Disease and Risk Factor Surveillance. Ann Intern Med 2020; 172 (4): 291. DOI: 10.7326/M19-0477

5.               Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

6.               Morgan OW, Bramley A, Fowlkes A et al. Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease. PLoS One 2010; 5 (3): e9694. DOI: 10.1371/journal.pone.0009694

7.               Moser J-AS, Galindo-Fraga A, Ortiz-Hernández AA et al. Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respi Viruses 2019; 13 (1): 3–9. DOI: 10.1111/irv.12618

8.               Viasus D, Paño‐Pardo JR, Pachón J et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 2011; 17 (5): 738–46. DOI: 10.1111/j.1469-0691.2010.03362.x

9.               Díaz E, Rodríguez A, Martin-Loeches I et al. Impact of Obesity in Patients Infected With 2009 Influenza A(H1N1). Chest 2011; 139 (2): 382–6. DOI: 10.1378/chest.10-1160

10.            Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Metab 2020; 318 (5): E736–41. DOI: 10.1152/ajpendo.00124.2020

11.            Peng YD, Meng K, Guan HQ et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48: 450–5. DOI: 10.3760/cma.j.cn112148-20200220-00105

12.            Cai Q, Chen F, Wang T et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020; 43 (7): 1392–8. DOI: 10.2337/dc20-0576

13.            Garg S, Kim L, Whitaker M et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (15): 458–64. DOI: 10.15585/mmwr.mm6915e3

14.            Richardson S, Hirsch JS, Narasimhan M et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; 323 (20): 2052–9. DOI: 10.1001/jama.2020.6775

15.            Klang E, Kassim G, Soffer S et al. Severe Obesity as an Independent Risk Factor for COVID‐19 Mortality in Hospitalized Patients Younger than 50. Obesity 2020; 28 (9): 1595-1599. DOI: 10.1002/oby.22913

16.            Petrilli CM, Jones SA, Yang J et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020;369:m1966. DOI: 10.1136/bmj.m1966

17.            Yang J, Hu J, Zhu C. Obesity aggravates COVID‐19: A systematic review and meta‐analysis. J Med Virol 2021; 93 (1): 257–61. DOI: 10.1002/jmv.26237

18.            Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections. Obes Rev 2015; 16 (12): 1017–29. DOI: 10.1111/obr.12320

19.            Richard C, Wadowski M, Goruk S et al. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Res Care 2017; 5 (1): e000379. DOI: 10.1136/bmjdrc-2016-000379

20.            Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 2020; 20 (5): 269-70. DOI: 10.1038/s41577-020-0308-3

21.            Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Metab 2020; 318 (5): E736–41. DOI: 10.1152/ajpendo.00124.2020

22.            Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117 (1): 175–84. DOI: 10.1172/JCI29881

23.            Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6 (10): 772–83. DOI: 10.1038/nri1937

24.            Cheng H, Wang Y, Wang G. Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19. J Med Virol 2020; 92 (7): 726–30. DOI: 10.1002/jmv.25785

25.            Kuba K, Imai Y, Rao S et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med 2005; 11 (8): 875–9. DOI: 10.1038/nm1267

26.            Ryan PM, Caplice NM. Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019? Obesity 2020; 28 (7): 1191–4. DOI: 10.1002/oby.22843

27.            Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol 2020; 16 (7): 341–2. DOI: 10.1038/s41574-020-0364-6

28.            Mangge H, Almer G, Truschnig-Wilders M, et al. Inflammation, Adiponectin, Obesity and Cardiovascular Risk. Curr Med Chem 2010; 17 (36): 4511–20. DOI: 10.2174/092986710794183006

29.            Kwaifa IK, Bahari H, Yong YK, Noor SM. Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules 2020; 10 (2): 291. DOI: 10.3390/biom10020291

30.            Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med 2018; 12 (9): 755–67. DOI: 10.1080/17476348.2018.1506331

31.            Memtsoudis SG, Ivascu NS, Pryor KO, Goldstein PA. Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea. Br J Anaesth 2020; 125 (2): e262–3. DOI: 10.1016/j.bja.2020.04.078

32.            Huang J-F, Wang X-B, Zheng KI et al. Letter to the Editor: Obesity hypoventilation syndrome and severe COVID-19. Metabolism 2020; 108 (4): 154249. DOI: 10.1016/j.metabol.2020.154249

33.            Pereira-Santos M, Costa PRF, Assis AMO, et al. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 2015; 16 (4): 341–9. DOI: 10.1111/obr.12239

34.            Gombart AF, Pierre A, Maggini S. A Review of Micronutrients and the Immune System–Working in Harmony to Reduce the Risk of Infection. Nutrients 2020; 12 (1): 236. DOI: 10.3390/nu12010236

35.            Fabbri A, Infante M, Ricordi C. Editorial - Vitamin D status: a key modulator of innate immunity and natural defense from acute viral respiratory infections. Eur Rev Med Pharmacol Sci 2020; 24: 4048–52. DOI: 10.26355/eurrev_202004_20876

36.            Dicker D, Bettini S, Farpour-Lambert N et al. Obesity and COVID-19: The Two Sides of the Coin. Obes Facts 2020; 13 (4): 430–8. DOI: 10.1159/000510005

37.            The Lancet Diabetes & Endocrinology. Obesity-related stigma—hiding in plain sight. Lancet Diabetes Endocrinol 2020; 8 (5): 349. DOI: 10.1016/S2213-8587(20)30123-6

38.            Frühbeck G, Baker JL, Busetto L et al. European Association for the Study of Obesity Position Statement on the Global COVID-19 Pandemic. Obes Facts 2020; 13 (2): 292-296. DOI: 10.1159/000508082

39.            Bornstein SR, Rubino F, Khunti K et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020; 8 (6): 546–50. DOI: 10.1016/S2213-8587(20)30152-2

40.            Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complications 2021; 35 (3): 107817. DOI: 10.1016/j.jdiacomp.2020.107817

41.            Yumuk V, Tsigos C, Fried M et al. European Guidelines for Obesity Management in Adults. Obes Facts 2015; 8 (6): 402–24. DOI: 10.1159/000442721